Probiotics for gastrointestinal disorders: Proposed Recommendations for children of the Asia-Pacific region

World Journal of Gastroenterology

Volumn 23, Issue 45, 2017, Pages 7952-7964

  Cameron, Donald ^a   Hock, Quak Seng ^b   Kadim, Musal ^c   Mohan, Neelam ^d   Ryoo, Eell ^e   Sandhu, Bhupinder ^f   Yamashiro, Yuichiro ^g   Jie, Chen ^h   Hoekstra, Hans ⁱ   Guarino, Alfredo ^j  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^d MEDANTA THE MEDICITY   (India)

^e Gachon University   (South Korea)

^f Royal Hospital for Children   (United Kingdom)

^g JUNTENDO UNIVERSITY   (Japan)

^h ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

ⁱ JEROEN BOSCH HOSPITAL   (Netherlands)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

more..

Author keywords

Asia Pacific; Children; Gastroenteritis; Guidelines; Lactobacilus rhamnosus; Probiotics; Recommendations; Saccharomyces boulardii

Indexed keywords

PROBIOTIC AGENT;

ACUTE GASTROENTERITIS; ANTIBIOTIC ASSOCIATED DIARRHEA; ASIA; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; INFANTILE COLIC; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; NECROTIZING ENTEROCOLITIS; NONHUMAN; NOSOCOMIAL DIARRHEA; PATIENT RISK; REVIEW; TRAVELLER DIARRHEA; TREATMENT OUTCOME; CULTURAL FACTOR; DEVELOPING COUNTRY; GASTROINTESTINAL TRACT; MICROBIOLOGY; PHYSIOLOGY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIOECONOMICS; STANDARDS;

ASIA; CHILD; CULTURAL CHARACTERISTICS; DEVELOPING COUNTRIES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS;

EID: 85038600760     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i45.7952     Document Type: Review

References (82)

1. Fischer Walker CL, Perin J, Aryee MJ, Boschi-Pinto C, Black RE. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health 2012;12:220 [PMID: 22436130 DOI: 10.1186/1471-2458-12-220]
2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-171 [PMID: 25530442 DOI: 10.1016/S0140-6736 (14) 61682-2]
3. Soenarto Y, Aman AT, Bakri A, Waluya H, Firmansyah A, Kadim M, Martiza I, Prasetyo D, Mulyani NS, Widowati T, Soetjiningsih, Karyana IP, Sukardi W, Bresee J, Widdowson MA. Burden of severe rotavirus diarrhea in indonesia. J Infect Dis 2009;200 Suppl 1:S188-S194 [PMID: 19821711 DOI: 10.1086/605338]
4. Sow SO, Muhsen K, Nasrin D, Blackwelder WC, Wu Y, Farag TH, Panchalingam S, Sur D, Zaidi AK, Faruque AS, Saha D, Adegbola R, Alonso PL, Breiman RF, Bassat Q, Tamboura B, Sanogo D, Onwuchekwa U, Manna B, Ramamurthy T, Kanungo S, Ahmed S, Qureshi S, Quadri F, Hossain A, Das SK, Antonio M, Hossain MJ, Mandomando I, Nhampossa T, Acácio S, Omore R, Oundo JO, Ochieng JB, Mintz ED, O'Reilly CE, Berkeley LY, Livio S, Tennant SM, Sommerfelt H, Nataro JP, Ziv-Baran T, Robins-Browne RM, Mishcherkin V, Zhang J, Liu J, Houpt ER, Kotloff KL, Levine MM. The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS). PLoS Negl Trop Dis 2016;10:e0004729 [PMID: 27219054 DOI: 10.1371/journal.pntd.0004729]
5. UNICEF, World Health Organization. Diarrhoea: why children are still dying and what can be done. 2009
6. World Health Organization. Western Pacific South-East Asia. Health in Asia and the Pacific. In: World Health Organization - Western Pacific South-East Asia, editor, 2008
7. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013;6:295-308 [PMID: 23814609 DOI: 10.1177/1756283X13482996]
8. Lagier JC, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol 2012;2:136 [PMID: 23130351 DOI: 10.3389/fcimb.2012.00136]
9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. Human gut microbiome viewed across age and geography. Nature 2012;486:222-227 [PMID: 22699611 DOI: 10.1038/nature11053]
10. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-514 [PMID: 24912386 DOI: 10.1038/nrgastro.2014.66]
11. Fiocchi A, Pawankar R, Cuello-Garcia C, Ahn K, Al-Hammadi S, Agarwal A, Beyer K, Burks W, Canonica GW, Ebisawa M, Gandhi S, Kamenwa R, Lee BW, Li H, Prescott S, Riva JJ, Rosenwasser L, Sampson H, Spigler M, Terracciano L, Vereda-Ortiz A, Waserman S, Yepes-Nuñez JJ, Brozek JL, Schünemann HJ. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics. World Allergy Organ J 2015;8:4 [PMID: 25628773 DOI: 10.1186/s40413-015-0055-2]
12. Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, Qamar AA, Miloh TA, Guarino A, Guslandi M, Dieleman LA, Ringel Y, Quigley EM, Brandt LJ. Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion. J Clin Gastroenterol 2015;49 Suppl 1:S69-S73 [PMID: 26447969 DOI: 10.1097/MCG.0000000000000420]
13. Thomas DW, Greer FR; American Academy of Pediatrics Committee on Nutrition; American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics 2010;126:1217-1231 [PMID: 21115585 DOI: 10.1542/peds.2010-2548]
14. Szajewska H. What are the indications for using probiotics in children? Arch Dis Child 2016;101:398-403 [PMID: 26347386 DOI: 10.1136/archdischild-2015-308656]
15. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926 [PMID: 18436948 DOI: 10.1136/bmj.39489.470347. AD]
16. Likert R. A technique for the measurement of attitudes. Arch Psychol 1932;22:1-55
17. Albano F, Lo Vecchio A, Guarino A. The applicability and efficacy of guidelines for the management of acute gastroenteritis in outpatient children: a field-randomized trial on primary care pediatricians. J Pediatr 2010;156:226-230 [PMID: 19836027 DOI: 10.1016/j.jpeds.2009.07.065]
18. D'Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta 2015;451:97-102 [PMID: 25584460 DOI: 10.1016/j.cca.2015.01.003]
19. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 2007;1:56-66 [PMID: 18043614 DOI: 10.1038/ismej.2007.3]
20. Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F, Schippa S. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol 2016;39:1-12 [PMID: 26922981]
21. Jalanka J, Salonen A, Fuentes S, de Vos WM. Microbial signatures in post-infectious irritable bowel syndrome-toward patient stratification for improved diagnostics and treatment. Gut Microbes 2015;6:364-369 [PMID: 26512631 DOI: 10.1080/1949 0976.2015.1096486]
22. Schippa S, Iebba V, Barbato M, Di Nardo G, Totino V, Checchi MP, Longhi C, Maiella G, Cucchiara S, Conte MP. A distinctive 'microbial signature' in celiac pediatric patients. BMC Microbiol 2010;10:175 [PMID: 20565734 DOI: 10.1186/1471-2180-10-175]
23. Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci 2015;16:7493-7519 [PMID: 25849657 DOI: 10.3390/ijms16047493]
24. Scanlan PD, Buckling A, Kong W, Wild Y, Lynch S V, Harrison F. Gut dysbiosis in cystic fibrosis. J Cyst Fibros 2012;11:454-455 [PMID: 22538067 DOI: 10.1016/j.jcf.2012.03.007]
25. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn S Y, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De León FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128 [PMID: 23245604 DOI: 10.1016/S0140-6736 (12) 61728-0]
26. World Health Organization, UNICEF. Ending preventable child deaths from pneumonia and diarrhoea by 2025; The integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). 2013
27. Mahapatra T, Mahapatra S, Babu GR, Tang W, Banerjee B, Mahapatra U, Das A. Cholera outbreaks in South and Southeast Asia: descriptive analysis, 2003-2012. Jpn J Infect Dis 2014;67:145-156 [PMID: 24858602]
28. Liu J, Platts-Mills JA, Juma J, Kabir F, Nkeze J, Okoi C, Operario DJ, Uddin J, Ahmed S, Alonso PL, Antonio M, Becker SM, Blackwelder WC, Breiman RF, Faruque AS, Fields B, Gratz J, Haque R, Hossain A, Hossain MJ, Jarju S, Qamar F, Iqbal NT, Kwambana B, Mandomando I, McMurry TL, Ochieng C, Ochieng JB, Ochieng M, Onyango C, Panchalingam S, Kalam A, Aziz F, Qureshi S, Ramamurthy T, Roberts JH, Saha D, Sow SO, Stroup SE, Sur D, Tamboura B, Taniuchi M, Tennant SM, Toema D, Wu Y, Zaidi A, Nataro JP, Kotloff KL, Levine MM, Houpt ER. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 2016;388:1291-1301 [PMID: 27673470 DOI: 10.1016/S0140-6736 (16) 31529-X]
29. Alam S, Mushtaq M. Antibiotic associated diarrhea in children. Indian Pediatr 2009;46:491-496 [PMID: 19556659]
30. Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011;16 Suppl 1:1-9 [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874.x]
31. Muhammad JS, Zaidi SF, Sugiyama T. Epidemiological ins and outs of helicobacter pylori: a review. J Pak Med Assoc 2012;62:955-959 [PMID: 23139983]
32. World Gastroenterology Organisation. Helicobacter Pylori in Developing Countries: World Gastroenterology Organisation Global Guidelines. 2010
33. Guarino A, Dupont C, Gorelov AV, Gottrand F, Lee JK, Lin Z, Lo Vecchio A, Nguyen TD, Salazar-Lindo E. The management of acute diarrhea in children in developed and developing areas: from evidence base to clinical practice. Expert Opin Pharmacother 2012;13:17-26 [PMID: 22106840 DOI: 10.1517/14656566.2011. 634800]
34. Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Lemair T, Kaufmann P, de Paula JA, Fedorak R, Shanahan F, Sanders ME, Szajewska H, Ramakrishna BS, Karakan T, Kim N; World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol 2012;46:468-481 [PMID: 22688142 DOI: 10.1097/MCG.0b013e3182549092]
35. Ritchie ML, Romanuk TN. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012;7:e34938 [PMID: 22529959 DOI: 10.1371/journal.pone.0034938]
36. Guarino A, Guandalini S, Lo Vecchio A. Probiotics for Prevention and Treatment of Diarrhea. J Clin Gastroenterol 2015;49 Suppl 1:S37-S45 [PMID: 26447963 DOI: 10.1097/MCG.0000000000000349]
37. Korterink JJ, Ockeloen L, Benninga MA, Tabbers MM, Hilbink M, Deckers-Kocken JM. Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis. Acta Paediatr 2014;103:365-372 [PMID: 24236577 DOI: 10.1111/apa.12513]
38. Szajewska H, Horvath A, Kolodziej M. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2015;41:1237-1245 [PMID: 25898944 DOI: 10.1111/apt.13214]
39. Urbanska M, Gieruszczak-Bialek D, Szajewska H. Systematic review with meta-analysis: Lactobacillus reuteri DSM 17938 for diarrhoeal diseases in children. Aliment Pharmacol Ther 2016;43:1025-1034 [PMID: 26991503 DOI: 10.1111/apt.13590]
40. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition; European Society for Pediatric Infectious Diseases. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 2014;59:132-152 [PMID: 24739189 DOI: 10.1097/MPG.0000000000000375]
41. Szajewska H, Canani RB, Guarino A, Hojsak I, Indrio F, Kolacek S, Orel R, Shamir R, Vandenplas Y, van Goudoever JB, Weizman Z; ESPGHAN Working Group for ProbioticsPrebiotics. Probiotics for the Prevention of Antibiotic-Associated Diarrhea in Children. J Pediatr Gastroenterol Nutr 2016;62:495-506 [PMID: 26756877 DOI: 10.1097/MPG.0000000000001081]
42. Luoto R, Isolauri E, Lehtonen L. Safety of Lactobacillus GG probiotic in infants with very low birth weight: twelve years of experience. Clin Infect Dis 2010;50:1327-1328 [PMID: 20367236 DOI: 10.1086/651694]
43. Lundelin K, Poussa T, Salminen S, Isolauri E. Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebocontrolled trials. Pediatr Allergy Immunol 2017;28:170-175 [PMID: 27779809 DOI: 10.1111/pai.12675]
44. Sanders ME, Akkermans LM, Haller D, Hammerman C, Heimbach J, Hörmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E. Safety assessment of probiotics for human use. Gut Microbes 2010;1:164-185 [PMID: 21327023 DOI: 10.4161/gmic.1.3.12127]
45. Wong A, Ngu D Y, Dan LA, Ooi A, Lim RL. Detection of antibiotic resistance in probiotics of dietary supplements. Nutr J 2015;14:95 [PMID: 26370532 DOI: 10.1186/s12937-015-0084-2]
46. Arora M, Baldi A. Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization. Indian J Med Microbiol 2015;33 Suppl: 2-10 [PMID: 25657150 DOI: 10.4103/0255-0857.150868]
47. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014;58:531-539 [PMID: 24614141 DOI: 10.1097/MPG.0000000000000320]
48. Bothra M, Bhatnagar S. Probiotics in pediatrics. Indian J Pediatr 2015;82:399-400 [PMID: 25689962 DOI: 10.1007/s12098-015-1719-1]
49. Hegar B, Waspada IM, Gunardi H, Vandenplas Y. A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children. Indian J Pediatr 2015;82:410-414 [PMID: 24777621 DOI: 10.1007/s12098-014-1408-5]
50. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V, Xóchihua L, Ybarra M, Zablah RA. The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Paediatr Drugs 2015;17:199-216 [PMID: 25799959 DOI: 10.1007/s40272-015-0124-6]
51. World Gastroenterology Organisation. Probiotics and prebiotics. 2011
52. Lo Vecchio A, Dias JA, Berkley JA, Boey C, Cohen MB, Cruchet S, Liguoro I, Salazar Lindo E, Sandhu B, Sherman P, Shimizu T, Guarino A. Comparison of Recommendations in Clinical Practice Guidelines for Acute Gastroenteritis in Children. J Pediatr Gastroenterol Nutr 2016;63:226-235 [PMID: 26835905 DOI: 10.1097/MPG.0000000000001133]
53. De T, Kondekar S, Rathi S. Hospital Based Prospective Observational Study to Audit the Prescription Practices and Outcomes of Paediatric Patients (6 months to 5 years age group) Presenting with Acute Diarrhea. J Clin Diagn Res 2016;10:SC01-SC05 [PMID: 27437317 DOI: 10.7860/JCDR/2016/19924.7810]
54. Lamberti LM, Ashraf S, Walker CL, Black RE. A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years. Pediatr Infect Dis J 2016;35:992-998 [PMID: 27254030 DOI: 10.1097/INF.0000000000001232]
55. Hajela N, Nair GB, Ganguly NK. Are probiotics a feasible intervention for prevention of diarrhoea in the developing world? Gut Pathog 2010;2:10 [PMID: 20799986 DOI: 10.1186/1757-4749-2-10]
56. Khamsarn S, Nampoonsak Y, Busamaro S, Tangkoskul T, Seenama C, Rattanaumpawan P, Boonyasiri A, Thamlikitkul V. Epidemiology of Antibiotic Use and Antimicrobial Resistance in Selected Communities in Thailand. J Med Assoc Thai 2016;99:270-275 [PMID: 27276737]
57. McFarland LV, Ozen M, Dinleyici EC, Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol 2016;22:3078-3104 [PMID: 27003987 DOI: 10.3748/wjg.v22.i11.3078]
58. Hickson M. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol 2011;4:185-197 [PMID: 21694803 DOI: 10.1177/1 756283X11399115]
59. Shan LS, Hou P, Wang ZJ, Liu FR, Chen N, Shu LH, Zhang H, Han XH, Han XX, Cai XX, Shang YX, Vandenplas Y. Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections. Benef Microbes 2013;4:329-334 [PMID: 24311316 DOI: 10.3920/BM2013.0008]
60. Na JY, Park JM, Lee KS, Kang JO, Oh SH, Kim YJ. Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective. Pediatr Gastroenterol Hepatol Nutr 2014;17:232-238 [PMID: 25587523 DOI: 10.5223/pghn. 2014.17.4.232]
61. Habib MI, Kazi SG, Ahmed Khan KM, Zia N. Rota virus Diarrhea in Hospitalized Children. J Coll Physicians Surg Pak 2014;24:114-117 [PMID: 24491006]
62. Oudhuis GJ, Bergmans DC, Verbon A. Probiotics for prevention of nosocomial infections: efficacy and adverse effects. Curr Opin Crit Care 2011;17:487-492 [PMID: 21900768 DOI: 10.1097/MCC.0b013e32834a4bab]
63. Bruzzese E, Fedele MC, Bruzzese D, Viscovo S, Giannattasio A, Mandato C, Siani P, Guarino A. Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo. Aliment Pharmacol Ther 2016;44:568-575 [PMID: 27464469 DOI: 10.1111/apt.13740]
64. Szajewska H, Wanke M, Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011;34:1079-1087 [PMID: 21899584 DOI: 10.1111/j.1365-2036.2011.04837.x]
65. Ashkenazi S, Schwartz E, O'Ryan M. Travelers' Diarrhea in Children: What Have We Learnt? Pediatr Infect Dis J 2016;35:698-700 [PMID: 26986771 DOI: 10.1097/INF.0000000000001145]
66. Ghoshal UC, Singh R. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population. J Gastroenterol Hepatol 2017;32:378-387 [PMID: 27262283 DOI: 10.1111/jgh.13465]
67. Francavilla R, Cristofori F, Indrio F. Indications and Recommendations by Societies and Institutions for the Use of Probiotics and Prebiotics in Paediatric Functional Intestinal Disorders. J Pediatr Gastroenterol Nutr 2016;63 Suppl 1:S36-S37 [PMID: 27380598 DOI: 10.1097/MPG.0000000000001220]
68. Giannetti E, Staiano A. Probiotics for Irritable Bowel Syndrome: Clinical Data in Children. J Pediatr Gastroenterol Nutr 2016;63 Suppl 1:S25-S26 [PMID: 27380595]
69. Harb T, Matsuyama M, David M, Hill RJ. Infant Colic-What works: A Systematic Review of Interventions for Breast-fed Infants. J Pediatr Gastroenterol Nutr 2016;62:668-686 [PMID: 26655941 DOI: 10.1097/MPG.0000000000001075]
70. Szajewska H, Dryl R. Probiotics for the Management of Infantile Colic. J Pediatr Gastroenterol Nutr 2016;63 Suppl 1:S22-S24 [PMID: 27380594]
71. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2006; CD004826 [PMID: 17054217 DOI: 10.1002/14651858. CD004826.pub2]
72. Ding Z, Zhao S, Gong S, Li Z, Mao M, Xu X, Zhou L. Prevalence and risk factors of Helicobacter pylori infection in asymptomatic Chinese children: a prospective, cross-sectional, population-based study. Aliment Pharmacol Ther 2015;42:1019-1026 [PMID: 26271484 DOI: 10.1111/apt.13364]
73. Wu MC, Sung CH, Chang YC, Ho CL, Wu CC, Wu KH, Lee CY, Yang KD. Seroprevalence of Helicobacter pylori and Hepatitis A Virus among Children in Rural Central Taiwan. Jpn J Infect Dis 2015;68:494-503 [PMID: 25866110 DOI: 10.7883/yoken. JJID.2014.321]
74. Nguyen TV, Bengtsson C, Nguyen GK, Yin L, Hoang TT, Phung DC, Sörberg M, Granström M. Age as risk factor for Helicobacter pylori recurrence in children in Vietnam. Helicobacter 2012;17:452-457 [PMID: 23066789 DOI: 10.1111/j.1523-5378.2012.00968.x]
75. Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol 2015;5:164-174 [PMID: 26413490 DOI: 10.5662/wjm.v5.i3.164]
76. Pacifico L, Osborn JF, Bonci E, Romaggioli S, Baldini R, Chiesa C. Probiotics for the treatment of Helicobacter pylori infection in children. World J Gastroenterol 2014;20:673-683 [PMID: 24574741 DOI: 10.3748/wjg.v20.i3.673]
77. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017;66:6-30 [PMID: 27707777 DOI: 10.1136/gutjnl-2016-312288]
78. Lü M, Yu S, Deng J, Yan Q, Yang C, Xia G, Zhou X. Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. PLoS One 2016;11:e0163743 [PMID: 27723762 DOI: 10.1371/journal.pone.0163743]
79. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evid Based Child Health 2014;9:584-671 [PMID: 25236307 DOI: 10.1002/ebch.1976]
80. Sawh SC, Deshpande S, Jansen S, Reynaert CJ, Jones PM. Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ 2016;4:e2429 [PMID: 27761306 DOI: 10.7717/peerj.2429]
81. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387:649-660 [PMID: 26628328 DOI: 10.1016/S0140-6736 (15) 01027-2]
82. Rosenfeld RM, Shiffman RN. Clinical practice guideline development manual: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg 2009;140:S1-S43 [PMID: 19464525 DOI: 10.1016/j.otohns.2009.04.015]